Biotech raises $315 million in IPO, surpassing $250M target
September 13, 2024 at 09:47 AM EDT
Bicara Therapeutics, led by CEO Claire Mazumdar, develops cancer drugs.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.